Prowell Ventures Pte Ltd - Net Worth and Insider Trading

Prowell Ventures Pte Ltd Net Worth

The estimated net worth of Prowell Ventures Pte Ltd is at least $142 Million dollars as of 2024-09-28. Prowell Ventures Pte Ltd is the 2201 Interest of corporation controlled by you of Biocytogen Pharmaceuticals (Beijing) Co Ltd and owns about 20,291,400 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) stock worth over $142 Million. Details can be seen in Prowell Ventures Pte Ltd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Prowell Ventures Pte Ltd has not made any transactions after 2022-09-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Prowell Ventures Pte Ltd

Prowell Ventures Pte Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Prowell Ventures Pte Ltd owns 1 companies in total, including Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) .

Click here to see the complete history of Prowell Ventures Pte Ltd’s form 4 insider trades.

Insider Ownership Summary of Prowell Ventures Pte Ltd

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:02315	Biocytogen Pharmaceuticals (Beijing) Co Ltd	2022-09-01	2201 Interest of corporation controlled by you

Prowell Ventures Pte Ltd Latest Holdings Summary

Prowell Ventures Pte Ltd currently owns a total of 1 stock. Prowell Ventures Pte Ltd owns 20,291,400 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) as of September 1, 2022, with a value of $142 Million.

Latest Holdings of Prowell Ventures Pte Ltd

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02315	Biocytogen Pharmaceuticals (Beijing) Co Ltd	2022-09-01	20,291,400	6.99	141,836,886

Holding Weightings of Prowell Ventures Pte Ltd

Prowell Ventures Pte Ltd Form 4 Trading Tracker

According to the SEC Form 4 filings, Prowell Ventures Pte Ltd has made a total of 1 transactions in Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Biocytogen Pharmaceuticals (Beijing) Co Ltd is the sale of 20,291,400 shares on September 1, 2022, which brought Prowell Ventures Pte Ltd around $0.

Insider Trading History of Prowell Ventures Pte Ltd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Prowell Ventures Pte Ltd Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Prowell Ventures Pte Ltd Ownership Network

Ownership Network List of Prowell Ventures Pte Ltd

No Data

Ownership Network Relation of Prowell Ventures Pte Ltd

Prowell Ventures Pte Ltd Owned Company Details

What does Biocytogen Pharmaceuticals (Beijing) Co Ltd do?

Who are the key executives at Biocytogen Pharmaceuticals (Beijing) Co Ltd?

Prowell Ventures Pte Ltd is the 2201 Interest of corporation controlled by you of Biocytogen Pharmaceuticals (Beijing) Co Ltd. Other key executives at Biocytogen Pharmaceuticals (Beijing) Co Ltd include 2201 Interest of corporation controlled by you BVCF Realization Fund GP, Ltd. , 2201 Interest of corporation controlled by you zhao yin guo ji jin rong you xian gong si , and 2201 Interest of corporation controlled by you zhao yin guo ji jin rong kong gu you xian gong si .

Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315)'s detailed insider trading history can be found in Insider Trading Tracker table.

Biocytogen Pharmaceuticals (Beijing) Co Ltd Insider Transactions

No Available Data

Prowell Ventures Pte Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Prowell Ventures Pte Ltd. Currently GuruFocus does not have mailing address information for Prowell Ventures Pte Ltd.

Discussions on Prowell Ventures Pte Ltd

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.